Stock comparison
GE HealthCare Technologies
Genmab A/S
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GEHC
GE HealthCare Technologies
Market cap
$29.22B
Sector
Healthcare
GMAB
Genmab A/S
Market cap
$16.5B
Sector
Healthcare
Overall winner
Genmab A/S GMAB
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GEHC | GMAB | Winner |
|---|---|---|---|
| Warren Buffett | 46D | 65C | GMAB |
| Benjamin Graham | 63C | 64C | GMAB |
| Philip Fisher | 33F | 48D | GMAB |
| Peter Lynch | 25F | 25F | Tie |
| Joel Greenblatt | 30F | 76B | GMAB |
| Charlie Munger | 45D | 68C | GMAB |
| Terry Smith | 34F | 71C | GMAB |
Side-by-side metrics
| Metric | GEHC | GMAB |
|---|---|---|
| Market cap | $29.22B | $16.5B |
| P/E (TTM) | 18.4x | 6.2x |
| EV/EBIT | 13.0x | 12.0x |
| ROIC (TTM) | 6.71% | 43.78% |
| Gross margin | 42.55% | 93.88% |
| Net margin | 7.54% | 18.23% |
| Revenue CAGR 5y | 4.07% | -18.45% |
| EPS CAGR 5y | -1.78% | -23.48% |
| Debt / Equity | 1.0x | 0.1x |
| Dividend yield | 0.23% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GEHC leads on
- Revenue CAGR 5y4.07%vs -18.45%+122%
- Dividend yield0.23%vs 0.0%+100%
- EPS CAGR 5y-1.78%vs -23.48%+92%
- Market cap$29.22Bvs $16.5B+44%
GMAB leads on
- Debt / Equity0.1xvs 1.0x+93%
- ROIC (TTM)43.78%vs 6.71%+85%
- P/E (TTM)6.2xvs 18.4x+67%
- Net margin18.23%vs 7.54%+59%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.